Haya S - Search Results

1

Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrate.

Aznar JA, Lorenzo JI, Molina R, Haya S, Querol F, Dasí MA. Aznar JA, et al. Among authors: haya s. Haemophilia. 1998 Jan;4(1):21-4. doi: 10.1046/j.1365-2516.1998.00139.x. Haemophilia. 1998. PMID: 9873861

2

Development of a factor VIII inhibitor in a newborn haemophiliac.

Haya S, Lorenzo JI, Dasí MA, Aznar JA. Haya S, et al. Haemophilia. 1998 Sep;4(5):755-6. doi: 10.1046/j.1365-2516.1998.00178.x. Haemophilia. 1998. PMID: 9873883

3

A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment.

Cid AR, Lorenzo JI, Haya S, Montoro JM, Casaña P, Aznar JA. Cid AR, et al. Among authors: haya s. Haemophilia. 2001 Jan;7(1):39-41. doi: 10.1046/j.1365-2516.2001.00478.x. Haemophilia. 2001. PMID: 11136379

4

Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry.

Haya S, López MF, Aznar JA, Batlle J; Spanish Immune Tolerance Group. Haya S, et al. Haemophilia. 2001 Mar;7(2):154-9. doi: 10.1046/j.1365-2516.2001.00469.x. Haemophilia. 2001. PMID: 11260274

5

Orthoses in haemophilia.

Querol F, Aznar JA, Haya S, Cid A. Querol F, et al. Among authors: haya s. Haemophilia. 2002 May;8(3):407-12. doi: 10.1046/j.1365-2516.2002.00637.x. Haemophilia. 2002. PMID: 12010442 Review.

6

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.

Cid AR, Casaña P, Cabrera N, Haya S, Cortina V, Aznar JA. Cid AR, et al. Among authors: haya s. Haemophilia. 2007 Mar;13(2):206-8. doi: 10.1111/j.1365-2516.2006.01422.x. Haemophilia. 2007. PMID: 17286776

7

Inhibitors in haemophilia A: current management and open issues.

Haya S, Moret A, Cid AR, Cortina V, Casaña P, Cabrera N, Aznar JA. Haya S, et al. Haemophilia. 2007 Dec;13 Suppl 5:52-60. doi: 10.1111/j.1365-2516.2007.01574.x. Haemophilia. 2007. PMID: 18078398 Review.

8

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.

Cid AR, Calabuig M, Cortina V, Casaña P, Haya S, Moret A, Cabrera N, Aznar JA. Cid AR, et al. Among authors: haya s. Haemophilia. 2008 Sep;14(5):1049-54. doi: 10.1111/j.1365-2516.2008.01781.x. Epub 2008 Jun 5. Haemophilia. 2008. PMID: 18540892

9

Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol).

Querol F, Cortina V, Cid AR, Haya S, Aznar JA. Querol F, et al. Among authors: haya s. Haemophilia. 2008 Nov;14 Suppl 6:36-44. doi: 10.1111/j.1365-2516.2008.01888.x. Haemophilia. 2008. PMID: 19134032

10

Severe and moderate hemophilia A: identification of 38 new genetic alterations.

Casaña P, Cabrera N, Cid AR, Haya S, Beneyto M, Espinós C, Cortina V, Dasí MA, Aznar JA. Casaña P, et al. Among authors: haya s. Haematologica. 2008 Jul;93(7):1091-4. doi: 10.3324/haematol.12344. Epub 2008 Apr 9. Haematologica. 2008. PMID: 18403393 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters